“…By contrast, increasing attention has been paid to the development of fluorescence imaging techniques for cancer theranostics in the second near-infrared window (NIR-II, 1000–1700) [ [7] , [8] , [9] ]. Since the biological tissues show less autofluorescence in NIR-II window than that in the visible (400–700 nm) or the first near-infrared window (NIR-I, 700–900) [ [10] , [11] , [12] , [13] ], NIR-II fluorescent probes can visualize the biological tissues with high temporal/spatial resolution and deep penetration [ [14] , [15] , [16] ]. However, most of the potential fluorescent probes do not exhibit a fluorescence signal in NIR-II window.…”